trending Market Intelligence /marketintelligence/en/news-insights/trending/hWXktwtR4PpF0SDFuOxjDA2 content esgSubNav
In This List

Biostage to delist from Nasdaq

Blog

Insight Weekly: Recession risk persists; Banks pull back from crypto; 2022 laggard stocks rally

Blog

Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage

Blog

Insight Weekly: Inflation eases; bank M&A slows; top companies boost market share

Blog

Insight Weekly: PE firms shift strategies; bank earnings kick off; bankruptcies plummet


Biostage to delist from Nasdaq

Biostage Inc. said Nasdaq will complete the delisting process for its common stock, after it failed to regain compliance with the rules.

The biotech company receive the notice of suspension in October. Concurrently, it started trading on the OTCQB marketplace under the symbol BSTG.

Biostage said the Nasdaq delisting will not affect its OTCQB marketplace listing.